Navigating the recent growth in asthma medications The National Asthma Council Australia has launched new resources to help inform health professions about treatment options.
Semaglutide shortage prompts caution around off-label prescribing GPs are being asked to prioritise the drug for people with diabetes, but with supplies critically low, what are the alternatives?
In Practice: Updates to COVID ‘existing relationship’ requirements The AskMBS Advisory has updated its existing relationship clarification for COVID-19 MBS telehealth services, including exemption categories.
Concern over significant NPS MedicineWise changes The recent budget revealed a ‘redesign’ for stewarding the quality use of medicines, with major implications for the organisation.
Thousands expected to benefit from new PBS listings Medications for asthma, HIV, and Crohn’s disease have been added, while some heart, cholesterol and blood pressure drugs are now cheaper.
At-risk COVID patients in WA directed to GPs for antiviral access The WA Department of Health has changed the mechanism for prescribing antiviral treatments through its COVID Care at Home program.
In Practice: AGPT applications opening Medical graduates pursuing a career in general practice will be able to register their interest in training with the RACGP in the coming weeks.
NPS MedicineWise partnership to strengthen the role of GPs The collaboration builds on a shared goal of improving quality use of medicines, clinical decision making and general practice education.
Which medicines could be in short supply in 2022? The pandemic has proven time and time again that it is a potent driver of shortages – but the end of COVID-induced medicine supply issues may come sooner than expected.
Taking the burden out of anticholinergic medicines A new program targeting the use of anticholinergic medicines has been launched by NPS MedicineWise.